This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1w6f
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1w6f" size="450" color="white" frame="true" align="right" spinBox="true" caption="1w6f, resolution 2.100Å" /> '''ARYLAMINE N-ACETYL...)
Next diff →
Revision as of 19:03, 29 October 2007
|
ARYLAMINE N-ACETYLTRANSFERASE FROM MYCOBACTERIUM SMEGMATIS WITH THE ANTI-TUBERCULAR DRUG ISONIAZID BOUND IN THE ACTIVE SITE.
Overview
Isoniazid is a frontline drug used in the treatment of tuberculosis (TB)., Isoniazid is a prodrug, requiring activation in the mycobacterial cell by, the catalase/peroxidase activity of the katG gene product. TB kills two, million people every year and the situation is getting worse due to the, increase in prevalence of HIV/AIDS and emergence of multidrug-resistant, strains of TB. Arylamine N-acetyltransferase (NAT) is a drug-metabolizing, enzyme (E.C. 2.1.3.5). NAT can acetylate isoniazid, transferring an acetyl, group from acetyl coenzyme A onto the terminal nitrogen of the drug, which, in its N-acetylated form is therapeutically inactive. The bacterium, responsible for TB, Mycobacterium tuberculosis, contains and expresses the, gene encoding the NAT protein. Isoniazid binds to the NAT ... [(full description)]
About this Structure
1W6F is a [Single protein] structure of sequence from [Mycobacterium smegmatis] with ISZ as [ligand]. Active as [[1]], with EC number [2.3.1.5]. Full crystallographic information is available from [OCA].
Reference
Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis., Sandy J, Holton S, Fullam E, Sim E, Noble M, Protein Sci. 2005 Mar;14(3):775-82. PMID:15722451
Page seeded by OCA on Mon Oct 29 21:08:21 2007
